207 related articles for article (PubMed ID: 21494556)
1. Rgs2 mediates pro-angiogenic function of myeloid derived suppressor cells in the tumor microenvironment via upregulation of MCP-1.
Boelte KC; Gordy LE; Joyce S; Thompson MA; Yang L; Lin PC
PLoS One; 2011 Apr; 6(4):e18534. PubMed ID: 21494556
[TBL] [Abstract][Full Text] [Related]
2. Dual negative roles of C/EBPα in the expansion and pro-tumor functions of MDSCs.
Mackert JR; Qu P; Min Y; Johnson PF; Yang L; Lin PC
Sci Rep; 2017 Oct; 7(1):14048. PubMed ID: 29070836
[TBL] [Abstract][Full Text] [Related]
3. Myeloid NEMO deficiency promotes tumor immunosuppression partly via MCP1-CCR2 axis.
Yuanyuan L; Yakun L; Zhongyao L; Le Y; Weisong D; Moran G; Hui B; Chunyan L
Exp Cell Res; 2021 Feb; 399(2):112467. PubMed ID: 33428904
[TBL] [Abstract][Full Text] [Related]
4. Expansion and functions of myeloid-derived suppressor cells in the tumor microenvironment.
Qu P; Wang LZ; Lin PC
Cancer Lett; 2016 Sep; 380(1):253-6. PubMed ID: 26519756
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-155 deficiency enhances the recruitment and functions of myeloid-derived suppressor cells in tumor microenvironment and promotes solid tumor growth.
Wang J; Yu F; Jia X; Iwanowycz S; Wang Y; Huang S; Ai W; Fan D
Int J Cancer; 2015 Mar; 136(6):E602-13. PubMed ID: 25143000
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of PLCγ2-β-catenin pathway promotes activation and expansion of myeloid-derived suppressor cells in cancer.
Capietto AH; Kim S; Sanford DE; Linehan DC; Hikida M; Kumosaki T; Novack DV; Faccio R
J Exp Med; 2013 Oct; 210(11):2257-71. PubMed ID: 24127488
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-494 is required for the accumulation and functions of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN.
Liu Y; Lai L; Chen Q; Song Y; Xu S; Ma F; Wang X; Wang J; Yu H; Cao X; Wang Q
J Immunol; 2012 Jun; 188(11):5500-10. PubMed ID: 22544933
[TBL] [Abstract][Full Text] [Related]
8. TIMP-2 targets tumor-associated myeloid suppressor cells with effects in cancer immune dysfunction and angiogenesis.
Guedez L; Jensen-Taubman S; Bourboulia D; Kwityn CJ; Wei B; Caterina J; Stetler-Stevenson WG
J Immunother; 2012 Jul; 35(6):502-12. PubMed ID: 22735808
[TBL] [Abstract][Full Text] [Related]
9. Myeloid-derived suppressor cells endow stem-like qualities to multiple myeloma cells by inducing piRNA-823 expression and DNMT3B activation.
Ai L; Mu S; Sun C; Fan F; Yan H; Qin Y; Cui G; Wang Y; Guo T; Mei H; Wang H; Hu Y
Mol Cancer; 2019 Apr; 18(1):88. PubMed ID: 30979371
[TBL] [Abstract][Full Text] [Related]
10. MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy.
Finke J; Ko J; Rini B; Rayman P; Ireland J; Cohen P
Int Immunopharmacol; 2011 Jul; 11(7):856-61. PubMed ID: 21315783
[TBL] [Abstract][Full Text] [Related]
11. Repression of MUC1 Promotes Expansion and Suppressive Function of Myeloid-Derived Suppressor Cells in Pancreatic and Breast Cancer Murine Models.
Sahraei M; Bose M; Sanders JA; De C; DasRoy L; Nath S; Brouwer CR; Mukherjee P
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070449
[TBL] [Abstract][Full Text] [Related]
12. ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment.
Bianchi G; Vuerich M; Pellegatti P; Marimpietri D; Emionite L; Marigo I; Bronte V; Di Virgilio F; Pistoia V; Raffaghello L
Cell Death Dis; 2014 Mar; 5(3):e1135. PubMed ID: 24651438
[TBL] [Abstract][Full Text] [Related]
13. Regulator of G protein signaling 2 deficiency causes endothelial dysfunction and impaired endothelium-derived hyperpolarizing factor-mediated relaxation by dysregulating Gi/o signaling.
Osei-Owusu P; Sabharwal R; Kaltenbronn KM; Rhee MH; Chapleau MW; Dietrich HH; Blumer KJ
J Biol Chem; 2012 Apr; 287(15):12541-9. PubMed ID: 22354966
[TBL] [Abstract][Full Text] [Related]
14. MDSCs mediate angiogenesis and predispose canine mammary tumor cells for metastasis via IL-28/IL-28RA (IFN-λ) signaling.
Mucha J; Majchrzak K; Taciak B; Hellmén E; Król M
PLoS One; 2014; 9(7):e103249. PubMed ID: 25075523
[TBL] [Abstract][Full Text] [Related]
15. Myeloid Derived Suppressor Cells Interactions With Natural Killer Cells and Pro-angiogenic Activities: Roles in Tumor Progression.
Bruno A; Mortara L; Baci D; Noonan DM; Albini A
Front Immunol; 2019; 10():771. PubMed ID: 31057536
[TBL] [Abstract][Full Text] [Related]
16. Ischemia induces regulator of G protein signaling 2 (RGS2) protein upregulation and enhances apoptosis in astrocytes.
Endale M; Kim SD; Lee WM; Kim S; Suk K; Cho JY; Park HJ; Wagley Y; Kim S; Oh JW; Rhee MH
Am J Physiol Cell Physiol; 2010 Mar; 298(3):C611-23. PubMed ID: 20032508
[TBL] [Abstract][Full Text] [Related]
17. Recruited monocytic myeloid-derived suppressor cells promote the arrest of tumor cells in the premetastatic niche through an IL-1β-mediated increase in E-selectin expression.
Shi H; Zhang J; Han X; Li H; Xie M; Sun Y; Liu W; Ba X; Zeng X
Int J Cancer; 2017 Mar; 140(6):1370-1383. PubMed ID: 27885671
[TBL] [Abstract][Full Text] [Related]
18. Dickkopf-related protein 1 (Dkk1) regulates the accumulation and function of myeloid derived suppressor cells in cancer.
D'Amico L; Mahajan S; Capietto AH; Yang Z; Zamani A; Ricci B; Bumpass DB; Meyer M; Su X; Wang-Gillam A; Weilbaecher K; Stewart SA; DeNardo DG; Faccio R
J Exp Med; 2016 May; 213(5):827-40. PubMed ID: 27045006
[TBL] [Abstract][Full Text] [Related]
19. Tumor-conditioned Gr-1(+)CD11b(+) myeloid cells induce angiogenesis through the synergistic action of CCL2 and CXCL16 in vitro.
Han EC; Lee J; Ryu SW; Choi C
Biochem Biophys Res Commun; 2014 Jan; 443(4):1218-25. PubMed ID: 24388986
[TBL] [Abstract][Full Text] [Related]
20. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma.
Yu SJ; Ma C; Heinrich B; Brown ZJ; Sandhu M; Zhang Q; Fu Q; Agdashian D; Rosato U; Korangy F; Greten TF
J Hepatol; 2019 Mar; 70(3):449-457. PubMed ID: 30414862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
